参考文献

1 Klein R，Klein BE，Moss SE．Visual impairment in diabetes[J]Ophthalmology，1984，91：1—9
2 Early Treatment Diabetic Retinopathy Study Research Group． Earlytreatment diabetic retinopathy study report number 1．Ph0t0coagu1ation f0rdiabetic macular edema[J]．Arch Ophthalmol，1985，103(12)：1796 —1806
3 Gilliies MC．Kuzniarz M ，Craig J，et a1．1ntravitreal triamcinolone-inducedelevated intraocular pressure is associated with the development ofposterior subcapsular cataract[J]．Ophthalmology，2005，1 12：139—143
4钱彤，黎晓新．玻璃体腔注射曲安奈德后的眼压改变[J]．中华眼底病杂志，2007，23：115—117
5 Nguyen QD，Shah SM，van Anden E，et a1．Supplemental oxygen improvesdiabetic macular edema：a pilot study[J]．Invest Ophthalmol Vis Sei，2004．45：617—624
6 Ferrara N．Vascular endothelial growth faetor：basic science and clinicalprogress[J]．Endoer Rev，2004，25：581—611
7 Mordenti J，Thomsen K．Licko V，et a1．Intraocular pharmacokineticsintravitreal administration of a solution or a PLGA microsphere formulation
『J]．Toxicol Sci，1999，52：l01一lO6
8 Shahar JS，Avry RL，Heilweil G，et a1．Elect rf】physio10gic and retinalpenetration studies following intravitreal injection of bevacizumab[J]Retina．2006．26：262—269
9 Rosenfeld PJ，Moshfeghi AA，Puliafito CA．Optical coherence tomographyfindings after an intravitreal injection of bevacizumab(Avastin)forneovaseular age—related macular degeneration[J J．Ophthalmic SurgLasers Imag．2005．36：33l一335
10 Avery RL，Pieramici DJ，Rabena MD，et a1．Intravitreal bevacizumab(Avastin)forneovaseular age—related macular degeneration[J]．Ophthalmology．2006．1l3：363—372
l l Rosenfeid PJ．Fung AE．Puliafito CA．Optical coherence tomographyfindings after an intravitreal injection of bevacizumab(Avastin)for maeular edema from central retinal vein occlusion[J]．Ophthalmic SurgLasers Imag，2005，36：336 —339
12 Arevalo JF，Fromow-Guerra J，Quiroz—Mercado H，et a1．Primaryintravitreal bevaeizumab(Avastin) for diabetic macular edema：resultsfrom the Pan．American Collaborative Retina Study Group at 6．monthfollow-up[J]．Ophthalmology，2007，l14：743—750
l 3 Soliman W ，Vinten M ，Sander B，et a1．Optical coherence tomography and
vessel diameter changes after intravitreal bevaeizumab in diabetic macular
edemai j 1．Aeta Ophthalmol Scand．2007，85：765—771
14 Haritoglou C，Kook D．Neubauer A ，et a1．Intravitreal bevacizumab(Avastin)therapy for persistent diffuse diabetic maeular edema[J]．Retina，2006，26：999—1005
15 Sakaguchi H，Gomi F，Kanmi M ，et a1．Complications in patients afterintravitreal injection of bevaeizumab l J]．Aeta Ophthalmol Scand，2007，
85：784—788
(收稿：2008—03—16 修回：2008—10—26)
(本文编辑：胡纯钢刘艳)

上一页  [1] [2] [3] [4] [5]